In contrast, studies between groups of COVID-19 patients showed that those with severe infection exhibited higher levels of naive CD8+ T cells and lower levels of effector CD8+ T cells and effector memory CD8+ T cells compared with patients with mild infection (Fenoglio et al., 2021), which may imply a defective cytotoxic lymphocyte response in severe infections. This evidence concerns the gene CD8A and COVID-19.